These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26850357)

  • 1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine.
    Bermejo-Martin JF; Andaluz-Ojeda D; Almansa R; Gandía F; Gómez-Herreras JI; Gomez-Sanchez E; Heredia-Rodríguez M; Eiros JM; Kelvin DJ; Tamayo E
    J Infect; 2016 May; 72(5):525-36. PubMed ID: 26850357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HIV infection on the host response to bacterial sepsis.
    Huson MA; Grobusch MP; van der Poll T
    Lancet Infect Dis; 2015 Jan; 15(1):95-108. PubMed ID: 25459220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked alterations of neutrophil functions during sepsis-induced immunosuppression.
    Demaret J; Venet F; Friggeri A; Cazalis MA; Plassais J; Jallades L; Malcus C; Poitevin-Later F; Textoris J; Lepape A; Monneret G
    J Leukoc Biol; 2015 Dec; 98(6):1081-90. PubMed ID: 26224052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
    Delano MJ; Ward PA
    J Clin Invest; 2016 Jan; 126(1):23-31. PubMed ID: 26727230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cell populations in sepsis and trauma.
    Venet F; Chung CS; Monneret G; Huang X; Horner B; Garber M; Ayala A
    J Leukoc Biol; 2008 Mar; 83(3):523-35. PubMed ID: 17913974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A divergent response of innate regulatory T-cells to sepsis in humans: circulating invariant natural killer T-cells are preserved.
    Heffernan DS; Monaghan SF; Chung CS; Cioffi WG; Gravenstein S; Ayala A
    Hum Immunol; 2014 Mar; 75(3):277-82. PubMed ID: 24269692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis.
    Nascimento DC; Alves-Filho JC; Sônego F; Fukada SY; Pereira MS; Benjamim C; Zamboni DS; Silva JS; Cunha FQ
    Crit Care Med; 2010 Aug; 38(8):1718-25. PubMed ID: 20543670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study.
    Wang JF; Li JB; Zhao YJ; Yi WJ; Bian JJ; Wan XJ; Zhu KM; Deng XM
    Anesthesiology; 2015 Apr; 122(4):852-63. PubMed ID: 25437496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Host immunosuppression in pathogenesis of sepsis and its clinical implication].
    Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):138-41. PubMed ID: 17376264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics.
    Kumar V
    Eur J Cell Biol; 2018 Aug; 97(6):379-392. PubMed ID: 29773345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of immune dysfunction in determining outcome in acute liver failure.
    Antoniades CG; Berry PA; Wendon JA; Vergani D
    J Hepatol; 2008 Nov; 49(5):845-61. PubMed ID: 18801592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis: a prospective pilot study.
    Yuan Y; Yan D; Han G; Gu G; Ren J
    J Crit Care; 2013 Dec; 28(6):1032-8. PubMed ID: 24216332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent remodeling of the immune system and its contribution to the predisposition of the elderly to infections.
    Dewan SK; Zheng SB; Xia SJ; Bill K
    Chin Med J (Engl); 2012 Sep; 125(18):3325-31. PubMed ID: 22964331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil extracellular traps in patients with sepsis.
    Hashiba M; Huq A; Tomino A; Hirakawa A; Hattori T; Miyabe H; Tsuda M; Takeyama N
    J Surg Res; 2015 Mar; 194(1):248-54. PubMed ID: 25438956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulation is a rational therapeutic strategy in sepsis.
    Pugin J
    Novartis Found Symp; 2007; 280():21-7; discussion 27-36, 160-4. PubMed ID: 17380786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.